Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |